Table 2. Summary of odds ratios (95%CI) in the analysis of the relationship of TNFSF13B with pSS susceptibility in pSS patients and Healthy Controls.
Publication bias
p
0.79 0.91 0.23 0.38 0.38 0.74 0.88 0.90 0.69 0.69 0.28 0.91 0.92 0.18 0.18 0.95 0.78 0.31 0.18 0.31 0.90
Egger’s test
0.27 -0.11 -1.20 0.88 -0.88 0.34 0.16 -0.12 0.39 -0.39 -2.10 -0.12 0.10 1.35 -1.35 -0.06 -0.27 1.03 -1.33 1.02 -0.12
Heterogeneity
I2(%)
56.74 46.94 -24.32 65.61 65.61 -718.34 -1592.91 5.43 -545.45 -545.45 57.36 -2.99 -7819.51 44.84 44.84 -27360.62 -1229.40 8.74 43.21 3.43 -6574.89
p
0.10 0.15 0.45 0.09 0.09 0.88 0.94 0.35 0.69 0.69 0.10 0.38 0.99 0.18 0.18 0.95 0.78 0.30 0.18 0.31 0.90
Q
4.62 3.77 1.61 2.91 2.91 0.24 0.12 2.11 0.15 0.15 4.69 1.94 0.03 1.81 1.81 0.00 0.08 1.10 1.76 1.04 0.01
Random effects
p
0.70 0.84 0.84
0.98
OR [95%CI]
0.92 [0.62-1.37] 0.95 [0.60-1.51] 1.05 [0.66-1.67]
0.99 [0.63-1.56]
Fixed effects
p
0.33 0.39 0.78 0.52 0.00 0.72 0.72 0.15 0.10 0.31 0.31 0.09 0.22 0.14 0.04 0.63 0.00
OR (95%CI)
1.14[0.88-1.47] 0.81[0.50-1.31] 0.96 [0.74-1.26] 0.91 [0.70-1.20] 4.62 [1.59-13.43] 0.95 [0.70-1.27] 1.06 [0.78-1.42] 0.83 [0.64-1.07] 1.33 [0.94-1.87] 0.88 [0.70-1.12] 1.13 [0.89-1.43] 0.75 [0.53-1.05] 1.24 [0.88-1.75] 2.32 [0.77-7.00] 0.73 [0.54-0.99] 1.08 [0.79-1.49] 2.55 [1.34-4.86]
Genotype/Allele
Genotype/Allele
TT TC CC T C AA AT TT A T CC CT TT C T TT GT GG TT TA AA
Study(n) Study(n) 3 3 3 2 2
Comparison Comparison rs9514827 rs1041569 rs9514828 rs1224141 rs12583006